Mark S. Blumenkranz
CIK 1614869 · last filed 2024-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$865.3K
Companies
5
Total Filings
32
Lifetime Open-Market Net
-$10.42M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KALA | Director | 181,545 | $2.63 | $477.5K | $0 | 5 | 2024-06-12 |
| IVERIC bio, Inc. (ISEE) Delisted | Director | 32,088 | $39.95 | $1.28M | $0 | 7 | 2023-05-19 |
| 1Life Healthcare Inc (ONEM) Delisted | Director | 4,534 | $16.47 | $74.7K | $0 | 3 | 2022-06-06 |
| Adverum Biotechnologies, Inc. (AAVL) Delisted | Director | 541,853 | — | — | -$10.42M | 14 | 2016-02-17 |
| LENS | Director | 9,270 | $41.84 | $387.9K | $0 | 1 | 2015-03-18 |
Recent Filings · Page 4 of 4
32 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-01-15 | Adverum Biotechnologies, Inc. (AAVL) Delisted | Sell (S) | −100,000 | -$5.55M | EDGAR |
| 2014-08-07 | Adverum Biotechnologies, Inc. (AAVL) Delisted | Mixed | +83,582 | $3.8K | EDGAR |
Showing 31–32 of 32
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.